Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shares were down 37.5% during mid-day trading on Wednesday . The stock traded as low as C$0.14 and last traded at C$0.15. Approximately 1,401,125 shares traded hands during trading, an increase of 162% from the average daily volume of 534,757 shares. The stock had previously closed at C$0.24.
Voyageur Pharmaceuticals Stock Performance
The firm’s 50 day simple moving average is C$0.10 and its 200 day simple moving average is C$0.07. The firm has a market cap of C$23.01 million, a PE ratio of -16.50 and a beta of 0.32. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Articles
- Five stocks we like better than Voyageur Pharmaceuticals
- 3 Ways To Invest In Coffee, Other Than Drinking It
- 3 Steel Stocks Soaring After Tariff Announcements
- What is an Earnings Surprise?
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
- P/E Ratio Calculation: How to Assess Stocks
- Why Salesforce Stock Could Be at Fresh Highs by February
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
